Laboratory Corporation of...

229.63
-2.04 (-0.88%)
At close: Mar 28, 2025, 3:59 PM
231.26
0.71%
Pre-market: Mar 31, 2025, 07:40 AM EDT

Covance Drug Development Revenue

History

Quarter Value Change Growth
Sep 30, 2024 737.7M 30.7M +4.34%
Jun 30, 2024 707M -3.9M -0.55%
Mar 31, 2024 710.9M -2.06B -74.37%
Dec 31, 2023 2.77B 2.06B +285.79%
Sep 30, 2023 719.1M 20.1M +2.88%
Jun 30, 2023 699M -702.3M -50.12%
Mar 31, 2023 1.4B -4.31B -75.46%
Dec 31, 2022 5.71B 3.5B +158.66%
Sep 30, 2022 2.21B -47.8M -2.12%
Jun 30, 2022 2.26B -198.7M -8.10%
Mar 31, 2022 2.45B -3.39B -58.02%
Dec 31, 2021 5.85B 3.23B +123.32%
Sep 30, 2021 2.62B 252M +10.65%
Jun 30, 2021 2.37B -392.3M -14.23%
Mar 31, 2021 2.76B -2.12B -43.46%
Dec 31, 2020 4.88B 2.17B +80.37%
Sep 30, 2020 2.7B 1.01B +59.76%
Jun 30, 2020 1.69B -9.3M -0.55%
Mar 31, 2020 1.7B -4.96B -74.45%
Dec 31, 2019 6.66B 4.9B +278.73%
Sep 30, 2019 1.76B -1.7M -0.10%
Jun 30, 2019 1.76B 38.9M +2.26%
Mar 31, 2019 1.72B -4.94B -74.16%
Dec 31, 2018 6.66B 4.91B +280.38%
Sep 30, 2018 1.75B -62M -3.42%
Jun 30, 2018 1.81B 43.8M +2.47%
Mar 31, 2018 1.77B -12.57B -87.66%
Dec 31, 2017 14.34B 12.5B +680.59%
Sep 30, 2017 1.84B 38.1M +2.12%
Jun 30, 2017 1.8B 81.2M +4.73%
Mar 31, 2017 1.72B -11.47B -86.97%
Dec 31, 2016 13.19B 11.52B +688.84%
Sep 30, 2016 1.67B 12.1M +0.73%
Jun 30, 2016 1.66B 69.1M +4.34%
Mar 31, 2016 1.59B -10.81B -87.17%
Dec 31, 2015 12.4B 6.15B +98.42%
Sep 30, 2015 6.25B 1.63B +35.20%
Jun 30, 2015 4.62B 3.15B +213.99%
Mar 31, 2015 1.47B 1.14B +346.87%
Dec 31, 2014 329.4M 246.5M +297.35%
Sep 30, 2014 82.9M -2.2M -2.59%
Jun 30, 2014 85.1M 4.7M +5.85%
Mar 31, 2014 80.4M -262.7M -76.57%
Dec 31, 2013 343.1M 261.4M +319.95%
Sep 30, 2013 81.7M n/a n/a
Jun 30, 2013 n/a n/a n/a